CORTEX PHARMACEUTIC Insiders

CORTEX PHARMACEUTIC Management Team Effectiveness

The company has Return on Asset of 0.0185 % which means that on every $100 spent on assets, it made $0.0185 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0555 %, implying that it generated $0.0555 on every 100 dollars invested. CORTEX PHARMACEUTIC's management efficiency ratios could be used to measure how well CORTEX PHARMACEUTIC manages its routine affairs as well as how well it operates its assets and liabilities.

CORTEX PHARMACEUTIC Workforce Comparison

The company has Net Profit Margin of 0.19 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of (0.04) %, which entails that for every $100 of revenue, it lost $0.04.

CORTEX PHARMACEUTIC Insider Trading

CORTEX PHARMACEUTIC Notable Stakeholders

The success or failure of an entity such as CORTEX PHARMACEUTIC often depends on how effective the management is. CORTEX PHARMACEUTIC management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CORTEX management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CORTEX management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in CORTEX PHARMACEUTIC's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CORTEX PHARMACEUTIC. Check CORTEX PHARMACEUTIC's Beneish M Score to see the likelihood of CORTEX PHARMACEUTIC's management manipulating its earnings.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

If you are still planning to invest in CORTEX PHARMACEUTIC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CORTEX PHARMACEUTIC's history and understand the potential risks before investing.